Using tPA for acute stroke in a rural setting.
Controversy continues regarding the safety and efficacy of tissue plasminogen activator (tPA) for stroke outside major centers. We reviewed charts from 1998 to 2004 of 493 patients admitted with TIA or stroke to our small rural hospital. There was a 4% tPA treatment rate with no symptomatic intracranial hemorrhage and zero mortality. IV tPA can be safe and effective in the treatment of acute stroke despite the size of the institution.
Edwards
Lorraine L
LL
Central Nebraska Neurology, 2727 W. 2nd Street, Suite 340, Hastings, NE 68901, USA. centralnn@alltel.net
D000208:Acute Disease; D006780:Hospitals, Rural; D006801:Humans; D012189:Retrospective Studies; D012424:Rural Population; D020521:Stroke / Q000188:drug therapy* / Q000201:enzymology* / Q000453:epidemiology; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D010959:Tissue Plasminogen Activator